Hypothesis

2 Matching Annotations

Apr 2026
aacrjournals.org aacrjournals.org

Targeting tumor microenvironment-derived NRG1-HER2/3 signaling with zenocutuzumab restores sensitivity to AR inhibition in PTEN wild-type prostate cancer

1
1. scibot 12 Apr 2026
  
  in Public
  
  RRID:AB_10707830
  
  DOI: 10.1158/1535-7163.MCT-25-0505
  
  Resource: (Santa Cruz Biotechnology Cat# sc-271872, RRID:AB_10707830)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_10707830
  
  What is this?
  
  RRID:AB_10707830
Visit annotations in context

Tags

RRID:AB_10707830

Annotators

scibot

URL

aacrjournals.org/mct/article/25/4/662/776472/Targeting-Tumor-Microenvironment-Derived-NRG1-HER2
Sep 2020
www.sciencedirect.com www.sciencedirect.com

Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation

1
1. scibot 23 Sep 2020
  
  in Public
  
  RRID:AB_10707830
  
  DOI: 10.1016/j.ccell.2020.03.001
  
  Resource: (Santa Cruz Biotechnology Cat# sc-271872, RRID:AB_10707830)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:AB_10707830
  
  What is this?
  
  RRID:AB_10707830 RRIDCUR:Validated
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:AB_10707830

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S153561082030101X